Delivery Order SPE2DB20D3103-SPE2DB24FP3S2

Award Date 7/1/24
Potential Completion Date 7/2/24
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,653.90 firm-fixed-price delivery order is for the supply of Fosamax 70 mg tablets, a drug used to treat osteoporosis. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle...
This federal contract award, SPE2DB22D3301|SPE2DB25FY0VS, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $52,268.87 firm fixed-price delivery order covers the supply of Fosamax 70 mg tablets, a medication used to treat osteoporosis. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,899.56 firm fixed-price delivery order contract is for the supply of FOSAMAX 70 MG Tablets to support federal healthcare programs. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,795.69 firm fixed-price contract is for the provision of Fosamax 70 mg tablets to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $12,833.65 firm fixed price delivery order is for the supply of Fosamax 70 mg tablets, a brand name pharmaceutical product, to support military treatment programs and facilities. The award is associated with a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,403.08 contract is for Fosamax 70 mg tablets, a prescription medication used to treat osteoporosis. The contract is a firm fixed-price delivery order, with an ultimate completion date of January 9, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, valued at $4,712.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fosamax 70 mg tablets, a medication used to treat osteoporosis. The award is a delivery order placed under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $12,437.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FOSAMAX 70 MG TABLET UU 4S, a medication used to treat osteoporosis. This is a firm-fixed-price delivery order contract with a completion date of February 4, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,040.57 delivery order contract is for the supply of the medication FOSAMAX 70 MG TABLET. The contract has a firm fixed price pricing type and a completion date of March 5, 2024. This award is a delivery order under a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $6,154.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,970,251 units of the medication Fosamax 70 mg tablet, with a completion date of May 18, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition....
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP3S2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,605.47 firm fixed-price delivery order is for the supply of Fosamax 70 mg tablets, a medication used to treat osteoporosis. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This agreement enables efficient government procurement of essential pharmaceutical products to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/17/25, 9:42 AM